Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03
Nyrada Inc has completed an in-vivo micronucleus on the effects of its NYR-BI03 drug on rats, suggesting it causes no genetic damage
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TEU | Ann: Results of Meeting | 21/11/12 | 0 | 492 | |||
|
|||||||
TEU | anyone out there | 01/11/12 | 1 | 678 | |||
|
|||||||
TEU | Ann: Quarterly Activities and Cashflow Report | 31/10/12 | 0 | 387 | |||
|
|||||||
TEU | Ann: Annual Report to shareholders | 30/10/12 | 0 | 525 | |||
|
|||||||
TEU | Ann: Notice of Annual General Meeting | 19/10/12 | 0 | 341 | |||
|
|||||||
TEU | Ann: Full Year Statutory Accounts | 28/09/12 | 0 | 381 | |||
|
|||||||
TEU | more cash in bank than market capitalisation | 12/08/12 | 2 | 623 | |||
|
|||||||
TEU | Ann: Progress Report | 06/08/12 | 0 | 314 | |||
|
See All Discussions